Apr 29, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,052 views The rise of oral GLP-1 medications is changing how clinicians approach type 2 diabetes treatment
Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease
Disruption of the normal gut microbiota may lead to intestinal dysbiosis, barrier dysfunction, bacterial translocation, and excessive production of uremic toxins, including indoxyl sulfate (IS), p-cresyl sulfate (p-CS), and trimethylamine-N-oxide (TMAO), all of which are implicated in the variant processes of kidney diseases development (Chen et al., 2019)
This is why residents in Franklin may prefer Zepbound for weight management, potentially resulting in more straightforward coverage
Therapy with probiotics and synbiotics for polycystic ovarian syndrome: a systematic review and meta-analysis
